TP53 and Miyoshi myopathy: Intriguingly, in a study conducted on MM patients treated with high-dose melphalan and ASCT support, OS and overall post-relapse survival were higher in cases with TP53 SNPs compared to wild-type careers, suggesting a favorable prognostic impact of TP53 codon72 SNP in this population [515].